Bevacizumab improves overall survival in platinum refractory ovarian cancer patients: A retrospective study
Objective: The objective of this study was to determine the effectiveness of bevacizumab (BV) in combination with chemotherapeutic regimens for prolonging progression-free survival (PFS) as well as overall survival (OS) in patients with platinum-refractory ovarian cancer. Materials and methods: We r...
Sparad:
| Huvudskapare: | , , , |
|---|---|
| Materialtyp: | Bok |
| Publicerad: |
Elsevier,
2018-12-01T00:00:00Z.
|
| Ämnen: | |
| Länkar: | Connect to this object online. |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signum: |
A1234.567 |
|---|---|
| Exemplar 1 | Tillgänglig |